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ABSTRACT
The reactions of bismuth(Ill) nitrate pentahydrate and bismuth(Ill) chloride with heterocyclic
thiosemicarbazones and derivatives of dithiocarbazonic acid methylester were used to synthe-
size the respective bismuth(Ill) complexes, which could be divided into five groups D-H be-
cause of their stoichiometrical properties and their molecular structures. The molecular
structure and the near coordination sphere of the bismuth(Ill) central atom of four representa-
tive compounds were determined by single-crystal X-ray studies. Bis[1-azepanyl-4-(2-pyridyl)-
2,3-diazapenta-l,3-diene-l-thiolato-N’,N3,S]bismuth(lll) nitrate (5) belongs to group D. The
two tridentate ligands and the nitrate ion surround the bismuth atom. The best description of
the coordination sphere appears to be that of a distorted trigonal dodecahedron with one posi-
tion occupied by the lone pair of the bismuth atom. Bis[1-azepanyl-4-(2-thienyl)-2,3-
diazapenta-l,3-diene-l-thiolato-N3,S]bismuth(lll) nitrate (9) is assigned to complex type E.
Here, two deprotonated ligand molecules are coordinated to the bismuth(Ill) central atom as
bidentate ligands. The structure of this complex can best be described as a distorted trigonal
antiprism with a five-coordinated central atom. The two triangular faces are formed by the at-
oms S(4), N(6), O(1 1) and S(3), N(4) and the lone pair of the central atom. The two chelate
rings are almost perpendicular to each other. Complex molecules of group F form dimeric
units with bichloro-bridged bismuth atoms. The structure of di-p-chlorobis[1-azepanyl-
4-(2-pyridyl)-2,3-diazapenta-l,3-diene-l-thiolato-N’,N,S-chloro]dibismuth(lll) (15)can be de-
scribed as two six-coordinated bismuth atoms, which are bound together via two bridging
chlorine atoms. The two bismuth atoms Bi(1) and Bi(la) and the two bridging chlorine atoms
C1(2) and Cl(2a) form the Bi2CI2 plane. The two tridentate ligand molecules coordinate via the
same atoms as shown in complex 5. In addition, they form two parallel planes, which are per-
pendicular to the Bi2CI= plane. With regard to the center of the Bi(1)-Bi(2) axis they are central
point symmetrical, i.e. one pyridine ring lies above and the other beneath the BiCI plane. Bis-
muth(Ill) chloride and pyridine-2-carboxaldehydethiosemicarbazone 1 b or 2-acetylpyridine-
thiosemicarbazone 1 c form complexes of group G. Three chlorine atoms and a bidentate li-
gand are coordinated to the bismuth(Ill) central atom. The bidentate ligand bound to the
central atom through the N(3) atom and the sulfur atom of the thioketo group. The structure
of 18 is completely different from the structures of the bismuth(Ill) complexes discussed so
far and was therefore assigned to group H. The bismuth central atom is coordinated with two
ligands, which are bound in different ways. One of them is deprotonated. This ligand is bound
to the central atom via the sulfur atom S(3) of the thiolate group and the N(5) atom. An inter-
action between the sulfur atom of the thiophene ring and the bismuth atom is not possible.
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The other ligand molecule is not deprotonated. This ligand is bound to the bismuth(Ill) cation
merely via the sulfur atom S(1) of the thioketo group. The best description of the coordination
sphere of the bismuth atom is that of a distorted square bipyramidal polyhedron. The square
face is formed by the atoms S(3), N(5), (31(1), the lone pair and the bismuth atom within. The
axial positions are occupied by the atoms S(1) and (31(2). The bond angle between S(1), Bi(1)
and C1(2) differs by about eight degrees from the value determined for a regular square
bipyramidal polyhedron of 180 degrees.
Some of the newly synthesized bismuth complexes and three ligands have been tested
against several strains of Helicobacter pylori bacteria in an agar dilution test. Almost all of the
listed bismuth complexes show excellent inhibitory properties with regard to growth of H. py-
Iori already at low concentrations.
INTRODUCTION
The stomach bacterium Helicobacter pylori (H. pylorl}, which was discovered as late as 1983,
is a pathogenic factor in the etiology of chronic gastritis and peptic ulcer.
1 Today, bismuth
complexes such as colloidal bismuth citrate (CBS), of which the X-ray crystal structure is
known, are used more frequently in the treatment of these diseases.
67 In the course of our re-
search into the development of new compounds with better antibacterial activity we found
that thiosemicarbazones would be suited for our intentions. Thiosemicarbazones have been
known as potential antiviral and antitumor agents since 1950. The first investigations with
thiosemicarbazones were carried out by Domagk, who observed considerable activity against
streptococcus. Various thiosemicarbazones have been shown to possess an increased activity
against influenza viruses, against a high number of protozoa, plasmodium berghei in mice and
also against some types of tumor.
611 Coordination of some thiosemicarbazones with transition
metal ions such as copper(ll), nickel(ll) etc. often increases their biological activities.
2
Thiosemicarbazones coordinate as multidentate ligands both to transition metals and non-
transition metals. Such complexes could be synthesized with, for example, iron, cobalt,
nickel, copper, silicon and lead as central atoms.
31 The first bismuth(Ill) complex with a
thiosemicarbazone derivative as ligand was published in 1992.
TM We now wish to report syn-
theses and single-crystal studies of bismuth(Ill) compounds with several thiosemicarbazones
and dithiocarbazonic acid methylesters. Some complexes have also been tested for antibacte-
rial activity against strains of H. pylori. Details of the syntheses, crystal structures, and tests
of antibacterial activity will be presented herein.
MATERIALS AND METHODS
The solvents were purified according to standard procedures.
7 The deuterated solvents were
purchased from Aldrich or Fluka and dried over 4 molecular sieves. Infrared spectra were
obtained on a BRUKER IFS 66 instrument with samples prepared as KBr pellets. H NMR- and
13C NMR spectra were recorded on a BRUKER AC spectrometer operating at 200 MHz. Mass
spectra were recorded on a FINNIGAN MAT. 8230. Molar conductivities were determined
with a WTW LF 191 conductometer operating with a Pt-electrode LS1/T-1.5. Elemental analy-
ses were carried out in our own laboratories. The bismuth content of the compounds was de-
termined by means of an ICP Plasma 400 from PERKIN ELMER. The following compounds
were prepared according to literature procedures, their formulae and their NMR numbering
272R. Diemer, U. Dittes, B. Nuber, V. Seifried,
W. Opferkuch andB.K. Keppler
schemes are listed in Scheme 1"
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formula 1/11 R1 R
2 compound
-CH3 -SCH3 1 a
H -NH2 1 b
-CH -NH= 1 c
-CH -N(CH)= 1 d
-CH -N(CH) 1 e
-CH3 a 1 f
-CHe b 1 g
-CH c 1 h
II (X S) -CH -SCH 1
II (X S) -CH3 b 1 k
II (X O) -CH -SCH 1 m
Scheme 1. Formulae of the used thiosemicarbazones and their NMR numbering schemes
3-[1-(2-Pyridyl)ethylidene]dithiocarbazonic acid methylester 1 a,
TM pyridine-2-carboxaldehyde-
thiosemicarbazone 1 b, TM, 2-acetylpyridinethiosemicarbazone 1 c,
TM 2-(N,N-dimethyl-
aminothiocarbonyl)- -[ -(2-pyridyl)ethylidene]hydrazine 1 d, 2-(N,N-diethylaminothiocar-
bonyl)-l-[1-(2-pyridyl)ethylidene]hydrazine 1 e,
1 2-(4-methylpiperidinothiocarbonyl)-l-[1-(2-
pyridyl)ethylidene]hydrazine 1 f,
lo 2-(hexamethyleneiminothiocarbonyl)-l-[1-(2-pyridylethy-lid-
ene]hydrazine 1 g,O 2-[(3-azabicyclo[3.2.2]nonane-3-yl)thiocarbonyl]- 1-[2-pyridyl)ethyli-
dene]hydrazine 1 h, 3-[1-(2-thienyl)ethylidene]dithiocarbazonic acid methylester 1 i,
TM
2-(hexamethyleneiminothiocarbonyl)-l-[1-(2-thienyl)ethylidene]hydrazine 1 k,
1 3-[1-(2-furyl)-
ethylidene]dithiocarbazonic acid methylester 1 m. TM Though no 1H NMR- and 1C NMR data is
listed for most of the compounds in the literature, Table gives a short summary of the most
important signals"
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N2-H H-5 H-7 H-8 H-9 H-10 H-12 to H- 5
1 a 12.57 2.49 8.05 7.84 7.41 8.76 2.42
(12)
8.56
1 c 10.32 2.36 8.42 7.76 7.36 8.55 8.40, 8.14 (NH2)
1 d 9.62 2.62 8.04 8.04 7.5 8.78 8.78
7.38 8.57
1 f 9.72 2.61 7.85 7.97 7.52 8.72 4.98 4.57
7.38 3.12 2.95
1.66
1 g 9,47 2.61 7,84 7.99 7,5 8,73 4.03(1) 1,76
1.66
("o)
1.1 5
0.92
(16)
1.48
N2-H H-5 H-7 H-8 H-9 H-12 H-13
1 12.56 2.63 7.68 7.27 7.79 2.53
1 k 13.3 2.69 7.91 7.33 8.13 3.96 1,76
9.42 2.29 7.45 7.05 7.56 3.85
1 m 12.34 2.28 7.04 6.63 7.86 2.48
Table 1. 1H-NMR Signals (5, DMSO-d6) of the ligands 1 a, 1 c-d and 1 f-m
General procedure A: 5.0 mmol of the ligand are dissolved in methanol (50 ml), water (40 ml)
and acetone (120 ml) under reflux. 2.3 mmol (1.12 g) of finely powdered Bi(NO3)3 5 H20 are
then added to the clear, light yellow solution and heated under reflux until a clear solution is
obtained. When bismuth nitrate is added, the colour of the solution turns into a dark yellow.
The hot solution is filtered and slowly evaporated within 30-40 minutes to give a final volume
of 60 ml. Then the solution is stored at room temperature for an hour. The resulting precipi-
tate is filtered off, washed twice with a mixture of water/methanol (1:1, 10 ml), then with
ether (20 ml) and finally dried over P4Olo under vacuum.
General procedure B: 4.0 mmol of the ligand are dissolved in acetone (100 ml), methanol (50
ml) and water (40 ml) under reflux. 3.5 mmol (1.1 g) of BiCI3, dissolved in methanol (10 ml)
and conc. HCI (0.3 ml), are added to the boiling reaction mixture within three minutes. The
mixture is heated under reflux until the orange solution is completely clear. The hot solution is
filtered and worked up as described in procedure A. Already during the distillation, a strongly
coloured yellow precipitate forms.
General procedure C: 4.0 mmol of the ligand are dissolved in methanol (150 ml) and water
(30 ml) under reflux. 3.8 mmol (1.2 g) of BiCI, dissolved in conc. HCI (2 ml) and methanol
(50 ml) are added to the boiling reaction mixture within 10 minutes. The colour of the mixture
turns into a deep yellow. After three minutes, a yellow precipitate forms, which is worked up
as usual.
1 Bis[ 1 -amino-4-(2-pyridyl)-2,3-diazabuta-1,3-diene- 1 -thiolato-N’,N%S]bismuth(ll I) nitrate
was prepared with the ligand 1 b by procedure A. Yield: 1.25 g (86%), m.p. 250C (dec.).
Anal. Calc. (found) for C,H,BiNOS2: C, 26.72 (26.81); H, 2.24 (2.32); N, 20.03 (19.88);
S, 10.19 (10.26). 1H NMR (, ppm, DMSO-de, 20C): 8.87 (d, J 5 Hz, 2 H, H-9), 8.72 (s,
2 H, H-4), 8.10 (dd, J 8 Hz, J =5 Hz, 2 H, H-7), 7.82 (d, J 5 Hz, 2 H, H-6), 7.58 (s, 4
H, NH2), 7.54 (m, 2 H, H-8). C NMR (, ppm, DMSO-de, 20C): 174.7 (1-C), 149.5 (5-C),
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149.1 19-C), 147.3 (4-C), 139.3 17-C), 126.1 18-C), 124.9 16-C). IR (KBr, eral): 3460 m,
33,54 m, 3279 s, 3162 s Iv N-x); 14,57 vs Iv C=N-N=C) UV {MoOH, Z,,,,x, rim): 384.7, 293.5,
248.5 AM (DMF): 74.4 [$cm2 tool
1 ].
(2) Bis[1-dimethyamin-4-(2-pyridy)-23-diazapenta-13-diene-1-thiat-NN3S]bismuth()
nitrate was prepared with the ligand 1 d by procedure A. Yield: 1.15 g (70%), m.p. 210C
(dec.). Anal. Calc. (found) for C2oH6BiNgO3S2: C, 33.66 (33.57); H, 3.67 (3.66); N, 17.67
(17.44); S, 8.99 (9.12). H NMR (, ppm, DMSO-d6, 20C): 8.93 (d, J 5 Hz, 2H, H-10),
8.11 (dd, J 8 Hz, J 5 Hz, 2 H, H-8), 8.04 (d, J 8 Hz, 2 H, H-7), 7.56 (dd, J 5 Hz,
J 8 Hz, 2 H, H-9), 3.33 (s, 12 H, H-13), 2.57 (s, 6 H, H-5). IR (KBr, cml): 2923 w (v
cl-x), 1391 vs (v C=N-N=C)’ UV (MeOH, Lmox, nm): 397.7, 302.2, 252.9. AM (DMF): 66.5 [Scm
mo1-1 ].
(3) Bis[ 1 -diethylamino-4-(2-pyridyl)-2,3-diazapenta-1,3-diene- 1 -thiolato-N’ ,N,S]bismuth(lll) ni-
trate was prepared with the ligand 1 by procedure A. Yield: 1.32 g (75%), m.p. 220C
(dec.). Anal. Calc. (found) for C4H,BiNgOSz: C, 37.45 (37.44); H, 4.45 (4.50); N, 16.38
(16.30); S, 8.33 (8.35). H NMR (5, ppm, DMSO-d, 20C): 8.93 (d, J 5 Hz, 2 H, H-10),
8.10 (dd, J 8 Hz, J 5 hz, 2 H, H-8), 8.02 (d, J 8 Hz, 2 H, H-7), 7.54 (dd, J 8 Hz,
J 5 Hz, 2 H, H-9), 3.70 (q, J 7 Hz, 8H, H-13), 2.58 (s, 6H, H-5), 1.08 (t, J 7 Hz,
12H, H-14). IR (KBr, cml): 2977 m, 2928 m, 2868 m (v c13-,), 1394 vs (v c=N-N=C)" UV
(MeOH, :mox, nm): 395.5, 316.9, 257.2. AM (DMF): 62.5 [Scm mol ].
(4) Bis[ 1 -(4-methylpiperidino)-4-(2-pyridyl)-2,3-diazapenta-1,3-diene- 1 -thiolato-N’,N,S]bis
muth (111) nitrate was prepared with the ligand 1 f by procedure A. Yield: 1.55 g (82%), m.p.
205C (dec.). Anal. Calc. (found) for C28HsBiNOS: C, 40.92 (40.84); H, 4.66 (4.85); N,
15.34 (15.25); S, 7.80 (7.68). 1H NMR (, ppm, DMSO-d, 20C): 8.93 (d, J 5 Hz, 2 H,
H-10), 8.12 (dd, J 8 Hz, J 5 Hz, 2 H, H-8), 8.04 (d, J 8 Hz, 2 H, H-7), 7.56 (dd, J
8 Hz, J 5 Hz, 2 H, H-9), 4.61 (m, 4 H, 13-Ho), 3.03 (m, 4 H, 13-Ho), 2.56 (s, 6 H, H-5),
1.61 (m, 6 H, 14o-H, 15-H), 1.00 (m, 4 H, 14-Ho), 0.87 (d, J 6 Hz, 6 H, H-16), (e equa-
torial, a axial). IR (KBr, cm): 2942 m, 2920 m, 2864 rn (Vcl.), 1430 vs (Vc=N.N=C). UV
(MeOH, Zo, nm): 399.8, 306.6, 252.9. AM (DMF): 62.5 [Scm mol
1 ].
(5) Bis[ 1 -azepanyl-4-(2-pyridyl)-2,3-diazapenta-1,3-diene- 1 -thiolato-N’,N3,S]bismuth(lll) nitrate
was prepared with the ligand 1 g by procedure A. Yield: 1.35 g (71%), m.p. 233C (dec.).
Anal. Calc. (found) for C=sHsBiNOS=: C, 40.92 (40.93); H, 4.66 (4.72); Bi, 25.43 (25.70);
N, 15.34 (1 5.23); S, 7.80 (7.75). 1H NMR (5, ppm, DMSO-d, 20C): 8.93 (d, J 5 Hz, 2H,
H-10), 8.12 (dd, J 8 Hz, J 5 Hz, 2 H, H-8), 8.02 (d, J 8 Hz, 2 H, H-7), 7.55 (dd, J
5 Hz, J 8 Hz, 2 H, H-9), 3.79 (m, 8 H, H-13), 2.57 (s, 6 H, H-5), 1.66 (m, 8 H, H-14),
1.45 (s, 8 H, H-15). 13C NMR (5, ppm, DMSO-d, 20C): 170.4 (1-C), 154.4 (4-C), 151.7
(6-C), 148.7 (10-C), 139.4 (8-C), 124.4 (9-C), 123.2 (7-C), 50.5 (13-C), 26.0 (14,15-C),
15.1 (5-C). IR (KBr, cm): 2925 s, 2825 m (v cl-,), 1417 vs (v C=N-N=C)" UV (MeOH, Z=x,
nm): 403.1, 305.5, 253.4. MS (FD): m/z 759 [M/-NO]. AM(DMF): 62.3 [Scmmol1].
(6) Bis[ 1 -(3-azabicyclo[3.2.2]nonane-3-yl-4-(2-pyridyl)-2,3-diazapenta-1,3-diene- i -thiolato-N’ ,-
N3,S] bismuth(Ill) nitrate (6) was prepared with the ligand 1 h by procedure A. Yield: 1.62 g
(80%), m.p. 247C (dec.). Anal. Calc. (found) for CH,2BiNOS: C, 43.98 (44.05); H, 4.84
(4.91); N, 14.43 (14.47); S, 7.34 (7.44). H NMR (5, ppm, DMSO-d6, 20C): 8.92 (d, J
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5 Hz, 2 H, H-10), 8.11 (dd, J 8 Hz, J ,5 Hz, 2 H, H-8), 8.02 (d, J 8 Hz, 2 H, H-7),
7.54 (dd, J 5 Hz, J 8 Hz, 2 H, H-9), 4.04 (m, 8 H, H-13), 2.,56 (s, 6 H, H-5), 1.93 (m,
4 H, H-14), 1.57 (m, 16 H, H-15). IF{ (KBr, cml) 2929 m, 2885 m, 2858 m (v C(13)-H), 1430
VS (V C=N-N=C)" UV (MeOH, X,, nm)" 402.8, 306.0, 254.3. AM (DMF)’ 64.0 [Scm mol" ].
(7) Bis[1methythi4(2pyridy)23diazapenta13diene1thiatN’N%S]bismuth() ni-
trate was prepared with the ligand 1 a by procedure A.Yield: 1.37 g (83%), m.p. 200C
(dec.). Anal. Calc. (found) for CsH2oBiNTOS4" C, 30.04 (29.98); H, 2.80 (2.91); Bi, 29.04
(29.00); N, 13.63 (13.55); S, 17.82 (17.58). H NMR (, ppm, DMSO-ds, 20C) 9.02 (d, J
5 Hz, 2 H, H-10), 8.30-8.20 (m, 4 H, H-7,8), 7.77 (m, 2 H, H-9), 2.77 (s, 6 H, H-13),
2.61 (s, 6 H, H-5). IR (KBr, cml) 1444 vs (Vc=N.N=C). UV (MeOH, Zm,X, nm)" 371.6, 316.3,
231.2. AM (DMF)" 66.6 [Scm2 mol
1 ].
(8) Bis[1amin4(2pyridy)23diazapenta-13diene1-thiatNN%S]bismuth() nitrate.
5.15 mmol of 1 c are dissolved in methanol (70 ml) and water (30 ml) under reflux. 2.5
mmol (1.2 g) of finely powdered Bi(NO) * 5 HzO are added to this solution. The reaction
mixture is heated under reflux for 20 minutes. A solution of 5.0 mmol (0.2 g) NaOH in water
(8 ml) is slowly added and the mixture is heated under reflux for another 5 minutes. After fil-
tration of the hot solution, the clear orange-yellow solution is evaporated at 50(3 to a final
volume of 70 ml and worked up as usual. Yield: 0.85 g (52%), m.p. 220(3 (dec.). Anal.
Calc. (found) for CHlsBiNgO3S=: C, 29.23 (29.07); H, 2.76 (2.93); Bi, 31.78 (30.50); N,
19.17 (19.14); S, 9.75 (9.99). 1H NMR (5, ppm, DMSO-d, 20(3): 8.95 (d, J 5 Hz, 2 H,
H-10), 8.10 (dd, J 8 Hz, J 5 Hz, 2 H, H-8), 8.00 (d, J 8 Hz, 2 H, H-7), 7.56 (dd, J
5 Hz, J 8 Hz, 2 H, H-9), 7.42 (s, 4 H, NHz), 2.54 (s, 6 H, H-5). CNMR ((, ppm,
DMSO-d6, 20C): 170.5 (1-C), 153.9 (4-(3), 151.6 (6-C), 148.6 (10-C), 139.4 (8-C), 124.6
(9-C), 123.4 (7-C), 15.2 (5-C). IR (KBr, cm): 3387 m, 3290 m, 3187 s, (v ,-H); 1453 VS (V
C=N-N=C) UV (MeOH, Zm,, nm): 379.8, 292.4, 249.6 AM (DMF): 65.7 [Scm2mol
1 ].
(9) Bis[1-azepany-4-(2-thieny)-2"3-diazapenta-1’3-diene-1-thiat-N%S]bismuth() nitrate.
5.0 mmol (1.41 g) of 1 k are dissolved in methanol (200 ml) under reflux. A suspension of
1.7 mmol (0.83 g) of finely powdered Bi(NO) 5 H20 in methanol (200 ml) is added to the
boiling reaction mixture in small portions to obtain a clear orange solution. After storage at
room temperature for two hours, orange-brown crystals separate, which are worked up as
usual. They are dried in the drying pistol at 100C / mbar. The crystal lattice of the result-
ing orange-brown crystals contains one molecule methanol per complex molecule. Yield: 1.08
g (76%), m.p. 176-180C (dec.). Anal. Calc. (found) for C6H36BiNTOS4: C, 37.54 (37.42);
H, 4.36 (4.37); Bi, 25.12 (25.70); N, 11.79 (11.75); S, 15.42 (15.59). HNMR (5, ppm,
DMSO-d6, 20C): 7.97 (d,J 5 Hz, 2 H, H-9), 7.80 (d,J 4 Hz, 2 H, H-7), 7.23 (t, J
4 Hz, 2 H, H-8), 3.97 (m, 8 H, H-12), 2.69 (s, 6 H, H-5), 1.76 (m, 8 H, H-13), 1.49 (m, 8 H,
H-14). C NMR (5, ppm, DMSO-de, 20C): 168.5 (1-C), 149.9 (4-C), 135.8 (6-C), 132.5
(7-C), 132.3 (9-C), 126.6 (8-C), 52.5 (12-C), 27.4 (13-C), 26.2 (5-C), 23.5 (14-C). IR (KBr,
cm): 2925 m, 2825 w (v C(13)-H)’ 1432 s (v C=N-N=C)’ UV (MeOH, :Z,o, nm): 365.7, 290.3,
251.2, 211.6. MS (FD): m/z 769 [M+-NO]. AM(DMF): 58.8 [Scm2mor ],
(10) Bis[ 1 -methylthio-4-(2-thienyl)-2,3-diazapenta-1,3-diene- 1 -thiolato-N3,S]bismuth(lll) ni-
trate. 5.0 mmol (1.1 5 g) of 1 are dissolved in methanol (120 ml) under reflux. A solution of
2.3 mmol (1.12 g) of finely powdered Bi(NOz) 5 HO in methanol (25 ml) and conc. HNOz
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(0.15 ml) is added to the boiling reaction mixture within one minute. On adding the bismuth
nitrate solution, a voluminous yellow-orange precipitate forms immediately. The reaction mix-
ture is heated for three minutes under reflux; then the hot suspension is filtered and the pre-
cipitate is worked up as described earlier. Yield: 1.25 g 174%), m.p. 170C Idec.). Anal. Calc.
Ifound) for C16H18BiNO356: C, 26.34 126.42); H, 2.49 12.47); Bi, 28.64 128.50); N, 9.60
19.60); $, 26.36 126.22). 1H NMR I, ppm, DM$O-d6, 20C): 8.09 Id, J [5 Hz, 2 H, H-9),
7.91 (d, J 4 Hz, 2 H, H-7), 7.25 Idd, J 4 Hz, J 5 Hz, 2 H, H-8), 2.78 Is, 6 H, H-12),
2.73 Is, 6 H, H-5). IR IKBr, cml): 1384 vs IVC:N.N=C). UV IMeOH, Xm,, rim): 344.5, 267.5,
212.7. AM IDMF): 47.6 [Scm mol
1 ].
(11) Bis[1-methylthio-4-(2-furyl)-2,3-diazapenta-1,3-diene-l-thiolato-N%S]bismuth(lll) nitrate.
5.0 mmol (1.07 g) of 1 m are dissolved in methanol (80 ml) under reflux. A suspension of 2.1
mmol (1.02 g) finely powdered Bi(NOz)z 5 H20 in methanol (60 ml) is added to the boiling re-
action mixture, then the clear orange solution is treated as described in procedure A. Yield:
0.78 g (53%), m.p. 170C (dec.). Anal. Calc. (found) for C1eH18BiNsO5S4: C, 27.55 (27.57);
H, 2.60 (2.73); Bi, 29.95 (30.80); N, 10.04 (9.81); S, 18.39 (18.19). 1H NMR (5, ppm,
DMSO-de, 20C): 7.99, 6.74 (d, J Hz, 2 H, H-9), 7.69, 7.34 (d, J 4 Hz, 2 H, H-7),
6.87, 6.63 (dd, J 4 Hz, J Hz, 2 H, H-8), 2.63, 2.45 (s, 6H, H-12), 2.55, 2.41 (s, 6 H,
H-5). IR (KBr, cml): 1462 vs (VC=N.N=C). MS (FD): m/z 635 [M+-NOz]. AM (DMF): 60.6 [Scm
mo1-1 ].
(12) Di-p-chlorobis[chloro( 1 -dimethylamino-4-(2-pyridyl)-2,3-diazapenta-1,3-diene-1 -thiolato-
N’,N%S)]dibismuth(lll) was prepared with the ligand 1 d by procedure B. Yield" 1.53 g (87%),
m.p. 270C (dec.). Anal. Calc. (found) for C2oH=eBizCI4NsS2" C, 23.97 (24.13); H, 2.61
(2.71); CI, 14.15 (14.10); N, 11.18 (11.03); S, 6.40 (6.35). 1H NMR (5, ppm, DMSO-d6,
20C) 9.08 (d, J 5 Hz, 2 H, H-10), 8.17 (dd, J 8 Hz, J 5 Hz, 2 H, H-8), 8.08 (d, J
8 Hz, 2 H, H-7), 7.63 (dd, J 5 Hz, J 8 Hz, 2 H, H-9), 3.40, 3.24 (s, 12 H, H-13),
2.57 (s, 6 H, H-5). IR (KBr, cml) 2925 w (v C(13)-H)’ 1395 vs (v C=N-N=C). UV (MeOH, 2.... nm)"
418.3, 333.1, 291.4, 256.1. AM(DMF)’ 7.5 [Scm2moll ].
(13) Di-t,-chlorobis[chloro(1 -diethylamino-4-(2-pyridyl)-2,3-diazapenta-1,3-diene- 1 -thiolato-N’ ,-
N%S)]dibismuth(lll) was prepared with the ligand 1 e by procedure B. Yield: 1.65 g (89%),
m.p. 247 251 C. Anal. Calc. (found) for C2H3BiCINS: C, 27.23 (27.29); H, 3.24 (3.27);
CI, 13.40 (13.81); N, 10.59 (10.55); S, 6.05 (6.07).1H NMR (5, ppm, DMSO-d6, 20C):
9.08, 8.94 (d, J 5 Hz, 2 H, H-10), 8.17 (dd, J 8 Hz, J 5 Hz, 2 H, H-8), 8.06 (d, J
8 Hz, 2 H, H-7), 7.62 (m, J 5 Hz, 2 H, H-9), 3.85,,3.70 (q, J 7 Hz, 8 H, H-13), 2.58 (s,
6 H, H-5), 1.18, 1.07 (t, J 7 Hz, 12 H, H-14). IR (KBr, cml): 2973 m, 2931 m, 2869 w (v
C(l)-H), 1393 VS (V C=N-N=C)" UV (MeOH, Zmox, nm): 418.8, 329.9, 290.8, 257.2. AM (DMF): 8.0
[Scm2 mo1-1 ].
(14) Di-p-chlorobis[chloro(1 -(4-methylpiperidino)-4-(2-pyridyl)-2,3-diazapenta-1,3-diene- 1 -thio-
lato-N’,N%S)]dibismuth(lll) was prepared with the ligand 1 f by procedure B. Yield: 1.75 g
(90%), m.p. 247- 250C. Anal. Calc. (found)for C=H8BizCI,NsS2: C, 30.28 (30.41); H, 3.45
(3.51); CI, 12.77 (13.04); N, 10.09 (10.00); S, 5.77 (5.67).1H NMR (5, ppm, DMSO-d6,
20C): 9.09, 8.95 (d, J 5 Hz, 2 H, H-10), 8.18 (dd, J 8 Hz, J 5 Hz, 2 H, H-8), 8.07
(d, J 8 Hz, 2 H, H-7), 7.64 (dd, J 5 Hz, J 8 Hz, 2 H, H-9), 4.78 (m, 4 H, 13-H.) 3.18
(m, 4 H, 13-H,), 2.57 (s, 6 H, H-5), 1.65 (m, 6 H, 14oH-,15), 1.15 (m, 4 H, 14-H,), 0.93 (d,
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6 H, H-16). IR (KBr, cm): 2947 m, 2923 m, 2864 m (v C(13)-H)’ 1432 vs (v C=N.N=C). UV
(MeOH, :kr,,, nm): 418.8, 334.8, 291.9, 257.2. AM (DMF): 8.2 [Scm2 mol" ].
(15) Di-p-chlorobis[ 1 -azepanyl-4-(2-pyridyl)-2,3-diazapenta-1,3-diene- 1 -thiolato-N’,Na,S-chlo
ro]dibismuth(lll) was prepared with the ligand 1 g by procedure B. Yield: 1.78 g (91%), m.p.
245 248C. Anal. Calc. (found) for C28H38Bi2CI4NsS2: (3, 30.28 (30.33); H, 3.45 (3.43); Bi,
37.64 (36.80); CI, 12.77 (12.94); N, 10.09 (9.87); S, 5.77 (5.79). 1H NMR (, ppm,
DMSO-ds, 20C): 9.08 (d, J 5 Hz, 2 H, H-10), 8.16 (m, J 8 Hz, 2 H, H-8), 8.05 (d, J
8 Hz, 2 H, H-7), 7.63 (m, J 5 Hz, 2 H, H-9), 4.00 (m, 8 H, H-13), 2.58 (s, 6 H, H-5), 1.76
(m, 8 H, H-14), 1.51 (m, 8 H, H-15). IR (KBr, cml): 2929 m, 2854 m (v c3-), 1421 vs (v
C=N-N=C)’ UV (MeOH, :Xno, nm): 419.4, 331.5, 293.6, 256.1. MS (FD): m/z 1073, 1075,
1077 (M/-CI). AM (DMF): 8.6 [Scm2 mol
1 ].
(16) Di-p-chrbis[1-(3-azabicyc[322]nnane-3-y)-4-(2-pyridy)-2’3-diazapenta-1"3-diene-
1-thiolato-N’,N,S-chloro]dibismuth(lll) was prepared with the ligand 1 h by procedure B.
Yield: 1.80 g (88%), m.p. 243 246C. Anal. Calc. (found) for C2H4Bi2CI,NsS: C, 33.06
(32.77); H, 3.64 (3.70); CI, 12.20 (12.27); N, 9.64 (9.42); S, 5.51 (5.40). H NMR (, ppm,
DMSO-d, 20C): 9.08, 8.95 (d, J 5 Hz, 2 H, H-10), 8.17 (dd, J 8 Hz, J 5 Hz, 2 H,
H-8), 8.05 (d, J 8 Hz, 2 H, H-7), 7.62, 7.54 (dd, J 5 Hz, J 8 Hz, 2 H, H-9), 4.17,
4.03 (m, 8 H, H-13), 2.57 (s, 6 H, H-5), 2.08, 1.99 (m, 4 H, H-14), 1.60 (m 16 H, H-15). IR
(KBr, cml): 2931 m, 2905 m, 2860 m (v cll-), 1430 vs (v c=-=c). UV (MeOH, Lr,ox, rim):
422.6, 338.0, 291.9, 257.7. AM (DMF): 9.6 [Scm mol ].
(17) Di-p-chlorobis[chloro( 1 -methylthio-4-(2-pyridyl)-2,3-diazapenta-1,3-diene- 1 -thiolato-N’,-
N,S)]dibismuth(lll) was prepared with the ligand 1 a by procedure B with a slight modifica-
tion. The ligand was dissolved in acetone (80 ml), methanol (50 ml) and water (25 ml). Yield:
1.66 g (94%), m.p. 240C (dec.). Anal. Calc. (found) for C=}H2oBiCI,N6S4: C, 21.44 (21.68);
H, 2.00 (2.05); Bi, 41.45 (41.30); CI, 14.06 (14.05); N, 8.33 (8.32); S, 12.72 (12.95). H
NMR (5’, ppm, DMSO-de, 20C): 9.19 (d, J 5 Hz, 2 H, H-10), 8.25 (m, 4 H, H-7H-,8),
7.79, 7.72 (dd, J 5 Hz, J 8 Hz, 2 H, H-9), 2.76, 2.72 (s, 6 H, H-13), 2.67, 2.57 (s, 6
H, H-5). IR (KBr, cm): 1437 vs (v C=N-N=C)" UV (MeOH, Xr,,, nm): 385.2, 329.9, 291o4,
242.0. AM (DMF): 7.8 [Scm mol ].
(18) 1 -Azepanyl-4-(2-thienyl)-2,3-diazapenta-1,3-diene- 1 -thiolato-N3,S]-[ 1 -azepanyl-4-(2-thi-
enyl)-2,3-diazapent-3-ene-l-thiolketo-S]dichlorobismuth(lll). 4.0 mmol (1.13 g) of 1 k are dis-
solved in methanol (110 ml) under reflux. 2.0 mmol (0.63 g) of BiCI in methanol (50 ml) and
conc. HCI (0.3 ml) are added to the boiling solution within three minutes. Then the solution is
worked up as described in procedure C. Yield: 0.92 g (55%), m.p. 174 177(3. Anal. Calc.
(found) for CzeH3TBiCI2NsS,: C, 37.10 (37.11); H, 4.43 (4.49); Bi, 24.83 (24.90); CI, 8.42
(8.60); N, 9.98 (9.99); S, 15.24 (15.25). H NMR (5’, ppm, DMSO-de, 20C): 9.42 (s, 1H,
NH), 8.12, 7.73, 7.54 (d, 2 H, H-9), 7.91, 7.49 (d, 2 H, H-7), 7.33, 7.19, 7.03 (dd, 2 H,
H-8), 3.95-3.85 (m, 8 H, H-12), 2.69, 2.63, 2.28 (s, 6 H, H-5), 1.77 (m, 8 H, H-13), 1.52
(m, 8 H, H-14). IR (KBr, cml): 2925 s, 2851 m (v c(a)-H), 1432 VS (V C=N-N=C), 1267 S (V C--S)
UV (MeOH, Xr,,, nm): 366.2, 290.8, 251.8, 213.3. MS (FD): m/z 804, 806 (M+-HCI). AM
(DMF): 3.0 [Scm mol ].
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|19) Pyridine-2-carboxyaldehydethiosemicarbazone-N3,S-trichlorobismuth(lll) was preoared
with the ligand 1 b by procedure C. Yield: 1.75 g (93%), m.p. 240C (dec.). Anal. Calc.
(found) for CTHsBiCI3N4S: C, 16.96 (17.13); H, 1.63 (1.77); CI, 21.46 (22.36); N, 11.31
(11.30); S, 6.47 (6.03). 1H NMR (, ppm, DMSO-d6, 20C): 11.78 (s, 1H, NH), 8.60 (d, J
5 Hz, H, H-9), 8.45, 8.29 (s, 2 H, NH2), 8.15 (d, J 8 Hz, H, H-6), 8.08 (s, H, H-4),
7.97 (dd, J 8 Hz, J 5 Hz, H, H-7), 7.50 (dd, J 5 Hz, J 8 Hz, H, H-8). 1C NMR
(#, ppm, DMSO-d6, 20C): 178.5 (1-C), 151.9 (5-C), 147.9 (9-C), 140.2 (4-C), 138.6 (7-C),
124.6 (8-C), 121.4 (6-C). IR (KBr, cm): 3322 m, 3258 s, 3167 s (v N-,); UV (MeOH, Xm,x.,
nm): 398.8, 322.3, 290.3, 249.6. AM (DMF): 74.5 [Scm mol ].
(20) 2-Acetylpyridinethiosemicarbazone-N,S-trichlorobismuth(lll) was prepared with the li-
gand 1 c by procedure C. Yield: 1.78 g (92%), m.p. 250C (dec.). Anal. Calc. (found) for
CsHloBiCI3N4S: C, 18.86 (19.37); H, 1.97 (1.99); CI, 20.87 (20.85); N, 10.99 (10.91); S,
6.29 (6.18). 1H NMR (#, ppm, DMSO-d, 20C): 10.35 (s, 1H, NH), 8.56 (d, J 5 Hz, H,
H-10), 8.42, 8.16 (s, 2 H, NH2), 8.43 (d, J 8 Hz, H, H-7), 7.80 (dd, J 8 Hz, J 5
Hz, H, H-8), 7.39 (dd, J 5 Hz, J 8 Hz, H, H-9), 2.37 (s, 3 H, H-5). IR (KBr, cm):
3393 m, 3248 s, 3170 s (v N.,). UV (MeOH, Xm,, nm): 404.2, 316.3, 289.2, 253.4. AM
(DMF): 77.3 [Scm
2 mol ].
The crystals needed for X-ray crystal structure analysis are produced as follows: g of the
bismuth complex is dissolved at 40C in as little methanol as possible. The clear solution is
heated within 5 minutes under reflux and is then filtered off at a high temperature. The solu-
tion is cooled down to room temperature and closed with a semipermeable membrane so the
methanol cannot evaporate but slowly. The mixtures are generally stored at room temperature
for a period of two to four weeks. The crystals are filtered off and dried. The crystals of 9
were immediately put into an impermeable matrix.
Activity of some bismuth(Ill) complexes against H. pylori. A number of bismuth(Ill) complexes
with thiosemicarbazone and dithiocarbazonic acid methylester derivatives as ligands and some
ligands themselves have been screened in an agar dilution test for their activity against H. py-
Iori. Five different strains of H. pylori are incubated for 24 hours under microaerophilic condi-
tions (5 % CO) in brain heart infusions at 37 C and supplemented with yeast extract (0.25
%), hermin (1%) and horse serum (10 %). The bismuth complexes, having been dissolved in
DMSO, are diluted with water in a geometrical dilution series to the corresponding concentra-
tions. These solutions are given onto blood agar plates (4 % sheep blood) in the order of fal-
ling concentrations 512 2 pg/ml. 20 pl of the bacterial suspension are spot inoculated on the
blood agar plates containing the dilutions of the bismuth complexes. After absorption of the
suspensions, the inoculum plates are incubated at 37 C in anaerobic jars with Anaerocult C
(Merck No. 16275), about 8-10 % by volume CO2 and 5-7 % by volume O2 for 5-6 days. The
lowest concentration of the bismuth complexes leading to complete inhibition of bacterial
growth was determined (in /Jg/ml agar). Reading of these minimal inhibitory concentration
(MIC) results is rather easy, reliable and reproducible with the agar-dilution method whereas
the broth-dilution leads to deviating results due to difficulties interpreting the turbidity.
Growth control experiments for nonsupplemented blood agar plates and blood agar plates
containing DMSO (2 %) for all strains are included for all strains. Table 2 shows the MIC val-
ues for some representative bismuth complexes and free ligands:
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Compound NCTC H.p. H.p. H.p. H.p.
11637 8981 16 43 72
1 f 25 10 10 10
4 10 10 0.5 10 10
1 g 10 5 < 0.2 2.5 10
5 10 10 5 10 10
1 h 25 10 < 0.2 5 25
6 25 10 10 10 25
16 O0 50 50 O0 O0
2 25 10 5 10 10
13 25 10 5 5 10
Table 2. Minimal inhibitory concentrations (MIC) in pg/ml of some bismuth complexes
against H. pylori.
Bismuth citrate, which is the preferred bismuth complex in the treatment of gastritic infec-
tions, shows MIC values between 16 > 64 pg/ml. With the exception of complex 16, all the
listed bismuth complexes show excellent inhibitory properties with regard to growth of H. py-
Iori already at low concentrations. By comparison of the obtained MIC values for free and co-
ordinated ligand molecules, the resulting bismuth(Ill) complexes are superior to the ligand
molecules themselves, which could be seen after the calculation of the relative ligand concen-
tration (RLC). As an example of this method, we compare the MIC values for the ligand 1 h
and the synthesized complex 6, obtained by reaction of 1 h with bismuth(Ill) nitrate pentahy-
drate, and the chlorobridged dimeric compound 16. Against the H.pylori strain NCTC 11637,
the MIC value for 1 h is 25pg/ml or 82.7 nmol/ml of 1 h. The MIC value for 6 is 25pg/ml or
28.6 nmol/ml of 6. Since the complex 6 contains two moles of ligand molecules per formula
unit, the resulting RLC is 57.2 nmol/ml for the ligand 1 h. Though dissociation of the complex
could not be observed under the conditions of the agar dilution test, the antibacterial activity
of the bismuth complex 6 depends not only upon the ligand’s activity itself. In relation to
compound 16, the RLC is 172.0 nmol/ml, so this compound is less effective against H.p. bac-
teria than the ligand. The new bismuth compounds could be used instead of bismuth citrate in
the triple-therapy, which consists of a bismuth compound, amoxicillin and metronidazole as an
alternative to the combination of the ATP-ase-inhibitor opremazole with either amoxicillin or
clarithromycin. 2’21 Both therapeutic regimes lead to an eradication rate of about 85-90 % and
have been proven to be the most successful regimes in many different studies.
The structures of the bismuth(Ill) complexes 5, 9, 15, and 18 could be elucidated by X-ray
crystal structure analyses. The crystal was mounted on a glass fibre and placed on a
Siemens-Stoe (AED II) diffractometer using a graphite-monochromated Mo-K= radiation (
71.073 pm).
2 The structure was solved by conventional Patterson and difference Fourier
methods using the SHELXTL-Plus program package,
z3 The function minimized during full-
matrix-least-squares refinement was Zwl/=( Fo-Fc with weights w 1/ (I Fol). Neutral
atom scattering factors and anomalous dispersion corrections for the non-hydrogen atoms
were taken from Ref. 24. A selection of bond distances and angles involving the bismuth atoms
is given in Tables 3-4, the fractional atomic coordinates are given in Tables 5-8:
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Metal BasedDrugs
atoms 5 9 15 18
Bi(1)-S(1) 2.584 (4) 2.583 (3) 2.992 (3)
Bi(1 )-S(2) 2.654 (4)
Bi(1)-S(3) 2.565 (4) 2.527 (3)
Bi(1 )-S(4) 2.561 (3)
Bi(1)-N(1) 2.711 (10) 2.501 (8)
Bi(1)-N(2) 2.471 (8) 2.355 (8)
Bi(1 )-N(4) 2.438 (10)
Bi(1)-N(5) 2.649 (9) 2.518 (8)
Bi(1)-N(6) 2.581 (8) 2.445 (11)
Bi(1 )-O(11 2.889 (11)
Bi(1 )-O(13) 2.731 (11)
Bi(1 )-C1(1 2.585 (3) 2.630 (4)
Bi(1)-CI(2) 2.791 (3) 2.605 (4)
Table 3. Selected Bond Distances (/,)
atoms 5 15 atoms 9 18
S(1)-Bi(1)-S(2)
S(2)-Bi(1)-N(1)
S(1)-Bi(1)-N(2)
S(2)-Bi(1)-N(2)
N(1)-Bi(1)-N(2)
N(1)-Bi(1)-S(1)
S(1)-Bi(1)-N(5)
S(2)-Bi(1)-N(5)
N(1)-Bi(1)-N(5)
N(2)-Bi(1)-N(5)
S(1)-Bi(1)-N(6)
S(2)-Bi(1)-N(6)
N(1)-Bi(1)-N(6)
N(2)-Bi(1)-N(6)
N(5)-Bi(1)-N(6)
N(1)-Bi(1)-O(13)
N(5)-Bi(1)-O(13)
CI(1)-Bi(1)-CI(2)
CI(1)-Bi(1)-N(1)
CI(2)-Bi(1)-N(1)
CI(1)-Bi(1)-N(2)
CI(2)-Bi(1)-N(2)
CI(1)-Bi(1)-S(1)
CI(2)-Bi(1)-S(1)
N(1)-Bi(1)-S(1)
92.3(1 S(3)-Bi(1 )-S(4)
86.1 (3) S(3)-Bi(1 )-N(4)
71.9(3) 74.8(2) S(4)-Bi(1 )-N(4)
73.9(3) S(3)-Bi(1 )-N(6)
63.0(3) 67.0(3) S(4)-Bi(1 )-N(6)
141.7(2) N(4)-Bi(1)-N(6)
73.4(2) C1(1 )-Bi(1 )-C1(2)
29.5(3) C1(1 )-Bi(1 )-S(1
38.4(4) CI(2)-Bi(1 )-S(1
138.6(3) C1(1 )-Bi(1 )-S(3)
91.2(2) CI(2)-Bi(1 )-S(3)
69.8(3) S(1 )-Bi(1 )-S(3)
30.6(3) C1(1 )-Bi(1 )-N(5)
139.2(4) CI(2)-Bi(1 )-N(5)
62.6(3) S(1 )-Bi(1 )-N(5)
70.6(3) S(3)-Bi(1 )-N(5)
79.2(3)
167.6 (1)
84.2(2)
84.9(2)
87.6(2)
82.6(2)
96.9 (1)
87.9 (1)
141.7(2)
Table 4. Selected Bond Angles (deg)
96.0(1)
73.2(2)
83.2(2)
81.2(2)
73.7(2)
143.3(3)
97.0(1)
84.3 (1)
172.0 (1)
82.9(1)
92.0(1)
96.1(1)
154.5(2)
91.1(2)
91.1(2)
72.7(2)
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atom x y z U,,qui,,.
Bi(1)
s()
S(2)
N(1)
N(2)
N(3)
N(4)
N(5)
N(6)
N(7)
N(8)
C(1)
C(2)
c(3)
c(4)
c(5)
c(6)
c(7)
c(8)
c(9)
c(o)
c(’’)
C(12)
C(13)
c(’4)
C(21)
C(22)
C(23)
C(24)
(25)
C(26)
C(27)
C(28)
C(29)
c(3o)
c(3)
C(32)
C(33)
C(34)
N(11)
o(’’)
O(12)
O(13)
2154( 1 1311 1 3030( 1 44( 1
3170(3) 322(1) 3060(3) 57(2)
3301 (3) 1862(2) 2047(3) 63(2)
2802(10) 2233(5) 4539(8) 60(6)
4296(8) 1368(5) 4567(7) 48(5)
5125(9) 992(4) 4534(8) 49(5)
5472(11 184(5) 3747(9) 58(6)
401(8) 521(4) 2110(9) 45(5)
884(9 1274(4 759(7) 46(5)
1094(9) 1658(4) 57(8 45(5)
2348(10 2321 (5) -93(9 59(6
2050(13) 2650(6) 4516(11) 64(8)
2417(15) 3082(6) 5366(12) 72(9)
3567(14) 3069(6) 6277(11) 63(8)
4351(13) 2652(6) 6311(11) 58(7)
3969(12) 2232(5) 5422(10) 48(6)
4768(12 1766(6) 5391 1 O) 55(7)
6087(10) 1754(5) 6305(9) 70(7)
4611(12) 520(6) 3819(10) 52(7)
6763(12) 361(6) 4261(13) 79(9)
7000(18) 743(8) 3471(20) 158(20)
6424(28) 610(11 2140(23) 179(26)
5844(37) 167(16) 1756(26) 380(47)
5038(20) -219(8) 1807(16) 142(16)
5202(14) -332(6) 3039(13) 85(9)
142(11) 130(5) 2690(10) 47(6)
-756(12) -253(6) 2241(11 61 (8)
-1513(13) -255(6) 1059(13) 69(9)
-1334(12) 160(5) 378(11) 57(7)
-383(11 540(5) 906(11 44(6)
-125(10) 975(5) 233(10) 44(6)
-1040(11 1086(5) -1076(9) 67(7)
2123(11 1937(5) 571(9) 41 (6)
1461(13) 2383(6) -1381(11) 81(9)
1655(18) 1939(7) -2107(13) 119(12)
2867(19) 1801(12) -1869(18) 199(18)
3858(19) 1885(11) -1094(18) 215(18)
4376(13) 2201(7) 26(14) 96(10)
3526(13) 2602(5) 234(11) 70(8)
929(11) 1200(5) 4795(10) 63(7)
328(8) 1526(4) 3938(7) 77(5)
530(12) 1073(6) 5443(10) 140(9)
1957(9) 1002(4) 4974(7) 76(5)
Table 5. Atomic Positional Parameters (x 10") and Equivalent Isotropic Displacement
Parameters (x 103) for 5
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Metal BasedDrugs
atom x y z U
Bi(1) 656(1) 4196(1) 1821(1) 46(1)
S(1) 2424(3) 383(3) 879(3) 68(2)
S(2) -651(3) 6554(3) 4784(2) 59(2)
S(3) -569(3) 2364(3) 2211(3) 62(2)
S(4) 2765(3) 5076(3) 3610(2) 63(2)
N(1) -488(10) 145(8) 1853(7) 63(5)
C(1) -18(12) -837(9) 1584(10) 69(7)
C(2) 1171(13) -832(12) 2495(10) 83(8)
C(3) 934(21) -1062(22) 3362(15) 174(19)
C(4) 176(23) -639(19) 3741(15) 150(19)
C(5) 1039(19) -566(25) 3174(15) 231(24)
C(6) 1477(13) 198(11 2236(12) 87(9)
N(2) 3097(8) 6361 (8) 5434(7) 57(5)
C(7) 2789(11 7082(10) 6136(9) 65(7)
C(8) 3025(13) 8356(11) 6103( 11 80(8)
C(9) 4291 (22) 9019(16) 6108(21 197(24)
C(10) 4998(18) 8601 (19) 5708(20) 170(19)
C(11 5389(13) 7552(15) 5713(13) 106(10)
C(12) 4531(11) 6485(11) 5848(10) 73(7)
C(13) 3581(15) 109(13) 577(12) 95(10)
C(14) 4440(15) 1136(14) 581(12) 103(11)
C(15) 4179(13) 2201(12) 820(11) 81(8)
C(16) 3072(10) 1918(10) 1003(8) 56(6)
C(17) -1944(11) 6882(11) 4867(10) 67(7)
C(18) -3016(13) 6508(12) 3900(11) 81(9)
C(19) -2806(11) 5942(11) 3092(10) 68(7)
C(20) 1560(10) 5895(9) 3442(8) 50(5)
N(3) 1003(8) 1475(7) 1553(6) 49(4)
N(4) 1546(8) 2623(7) 1528(6) 45(4)
N(5) 1014(8) 5873(7) 4113(7) 49(4)
N(6) 103(8) 5293(7) 3065(7) 47(4)
C(21 1070(10) 5328(9 2778(8 48(5)
C(22) -2058(10) 4722(11 1633(9) 72(7)
C(23) 2502(10) 2802(9) 1261 (8) 51 (5)
C(24) 3123(10) 4078(9) 1242(9) 65(6)
C(25) 58(10) 1282(9) 1836(8) 48(5)
C(26) 2179(10) 5810(9) 4402(8) 47(5)
N(11) 1084(11) 6595(8) 828(8) 63(6)
O(11) 1931(9) 6511(8) 1631(7) 91(5)
O(12) 1476(9) 7131 (8) 292(7) 93(6)
O(13) -118(9) 6144(8) 571(7) 86(5)
C(27) 4171 (16) 7152(17) 889(15) 124(12)
C(28) 4949(16) 7687(18) 1862(17) 147(14)
Table 6. Atomic Positional Parameters (x 104) and Equivalent Isotropic Displacement
Parameters (x 103) for 9.
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atom x y z Ue..,,,
Bi(1) 1361(1) 1020(1) 4849(1) 31(1)
C1(1 3009(3) 2129(3) 5923(2) 64(1)
C1(2) -127(3) 29(2) 3372(2) 43(1)
C(1 2009(11 2581(7) 3225(6) 33(3)
C(2) 3365(11) 2010(7) 3227(6) 33(3)
N(1 3402(9) 1184(7) 3727(5) 38(3)
C(3) 4578(12) 618(9) 3747(7) 52(4)
C(4) 5813(12) 851 (10) 3249(8) 60(5)
C(5) 5822(13) 1680(10) 2747(7) 60(5)
C(6) 4599(12) 2265(8) 2725(6) 43(4)
C(7) 1752(13) 3401 (7) 2572(6) 53(4)
N(2) 1011(9) 2322(6) 3805(5) 35(3)
N(3) -257(9) 2862(6) 3774(5) 37(3)
C(8) -1283(11 2646(7) 4378(6) 31 (3)
S(1) -1166(3) 1753(2) 5243(2) 37(1)
N(4) -2547(9) 3159(6) 4295(5) 38(3)
C(9) -2652(12) 3984(8) 3653(7) 48(4)
C(10) 1992(14) 4893(9) 4089(9) 65(5)
C(11) -2293(20) 5100(11) 5086(9) 94(7)
C(12) -2596(30) 4521 (14) 5739( 11 241 (18)
C(13) -3426(14) 3668(8) 5870(7) 55(5)
C(14) -3728(11) 3070(8) 4960(6) 43(4)
Table 7. Atomic Positional Parameters (x 104) and Equivalent Isotropic Displacement
Parameters (x 103) for 15.
atom x y z U..u.
Bi(1) 1963(1) 501(1) 3961(1) 48(1)
C1(1) 2149(3) 839(3) 5773(2) 71(1)
CI(2 2071 (3) 2549(3) 3298(3) 85(2
S(1) 1426(2) -1687(2) 4832(2) 64(1)
C(1 2671(9) -3064(8) 4133(7) 53(5)
N( 1 3888(7) -3458(7) 4104(6) 55(4)
N(2) 4051(8) -2704(7) 4718(6) 56(4)
C(2) 5162(9) -2934(9) 4797(8) 56(5)
C(3) 5184(10) -2016(9) 5500(8) 72(6)
C(4) 6339(10) -3997(9) 4239(8) 61(5)
C(5) 7550(11) -4254(11 4309(10) 77(6)
C(6) 8478(12) -5356(13) 3682(11) 102(8)
C(7) 8026(13) -5906(12) 3151(11) 96(8)
S(2) 6448(3) -5120(3) 3397(3) 77(2)
N(3) 2426(8) -3841(7) 3618(6) 59(4)
C(8) 1118(11) .3623(11) 3631(9) 80(7)
C(9) 1138(18) -3608(21) 2604(15) 225(19)
C(10) 2163(25) -3806(18) 1580(15) 170(20)
C(11) 3506(22) -4309(22) 1272(16) 263(21)
C(12) 4260(14) -4756(13) 1857(11) 105(8)
C(13) 3496(11) -4930(9) 2968(9) 71(6)
S(3) 4460(2) -445(2) 3221(2) 58(1
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C(14) 4925(10) -989(11) 1879(9) 82(6)
N(4) 4149(8) -962(9) 1412(7) 78(5)
N(5) 2806(8) -447(7) 2055(6) 58(4)
C(15) 2028(9) -424(9) 1604(7) 55(5)
C(16) 565(10) 186(12) 2254(8) 85(6)
C(17) 2435(11) -959(9) 513(8) 65(5)
C(18) 1597(13) -1084(11) 83(9) 85(7)
C(19) 2235(18) -1595(14) -985(13) 122(11
C(20) 3547(20) -1898(15) -1353(11) 146(12)
S(4) 4066(4) -1520(4) -451(3) 102(2)
N(6) 6213(10) -1488(14) 1277(9) 148(8)
C(21) 6763(17) -1984(17) 16(14) 152(7)
C(22) 8158(24) -2818(22) -519(20) 246(13)
C(23) 7970(34) -3650(31) 264(27) 411(26)
C(24) 8832(23) -3374(20) 925(18) 210(10)
C(25) 7833(21) -2511(17) 1819(16) 174(8)
C(26) 7289(16) -1336(15) 1613(t4) 132(6)
Table 8. Atomic Positional Parameters (x 104) and Equivalent Isotropic Displacement
Parameters (x 103) for 18.
Results and Discussion
Reaction of bismuth(Ill)chloride (BiCI3) or bismuth(Ill)nitrate Bi(NO3)3 5 H20 with thiosemicar-
bazones and dithiocarbazonic acid methylester derivatives forms bismuth(Ill)complexes with
different molecular structures and stoichiometrical content. Therefore the synthesized bismuth
compounds are divided into five groups named D H. It was possible to resolve the molecular
structures of four representative complexes (5, 9, 15, 18) by means of crystal structure
analysis.
In the bismuth complexes of group D (1-8), two tridentate ligands and one nitrate are coordi-
nated to the bismuth(Ill) central atom, the latter via one of its oxygen atoms. In a keto enol
tautomerism, the thioketo group is converted into a thiolate group while the proton of the
H-N(2) group is split off. Owing to the additional C=N double bond, a conjugated double
binding system is formed in the ligand, which contributes considerably to the stabilization of
the complexes. Scheme 2 displays the thioketo-enol tautomerism and the complexation possi-
bilities of the pyridine ring containing ligands.
Scheme 2. Thioketo-enol tautomerism and complexation possibilities of thiosemicarba-
zones containing a pyridine heterocycle
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The ligands are bound, as tridentate ligands, to the central atom through the nitrogen atom of
the pyridine ring, the nitrogen atom of the C N double bond and the sulfur atom of the thio-
late group. The non-bound thiosemicarbazone and dithiocarbazonic acid methylester deriva-
tives can have different stereoisomeric forms (e.g. cis-trans-isomerism with respect to the
C =N double bond). Therefore, the 1H NMR spectra of the free ligands show several signals
for the same proton. In the 1H NMR spectra of the bismuth(Ill) complexes of type D there is,
in each case, exactly one signal for the aromatic and magnetically equivalent protons; i.e., the
bound ligand has exactly the stereoisomeric form that has been mentioned above. For the four
protons of the pyridine ring H-7 and H-10, two doublets are observed and for H-8 and H-9
one doublet in the range between 7.5 and 9.0 ppm. The pyridine nitrogen binds through the
free electron pair. The decreased electron density in the ring system effects a deshielding of
the protons and thus a shift to low field by 0.1 0.4 ppm. This downfield shift can be ob-
served in the complexes of group D and F.
The structure of compound 5, a typical representative of the complex group D, can be de-
scribed as follows. Two deprotonated molecules of 1 g are configurated to the bismuth(Ill)
cation as tridentate ligands. Except for the hexamethyleneimine ring, the ligand lies on the
same plane. The bismuth atom is seven coordinated, as shown in Figure 1. The best
description appears to be that of a distorted trigonal dodecahedron with one position occupied
by the lone pair of the bismuth atom. Due to this, the Bi(1)-S(2) bond distance near to this
electron pair is somewhat longer than the Bi(1)-S(1) bond distance. All of the calculated Bi-N
distances differ from each other, the distances between the central bismuth atom and the N-
atom of the pyridine rings (N(1), N(5)) are longer than the distances between Bi(1) and the
C=N bounded N(2) and N(6). The bonding distance between Bi(1) and O(13) (273.1 pm) is
distinctly smaller than the sum of their van der Waals radii (360 pm) and should be treated as
polar interactions.
2-27 In the FD mass spectrum, a peak was found at m/z 759, which cor-
responds to the fragment [(Lig)2Bi+], i.e. the nitrate ion was split off. The molar conductivity
AM of 5 measured in DMF is 62.3 [Scm=mol]. All bismuth complexes of group D show molar
conductivities in the range between 62-75 [Scmmol] and therefore behave as 1:1
electrolytes.
=8
Figure 1.
2
SCHAKAL-plot of Bis[ 1-azepanyl-4-(2-pyridyl)-2,3-diazapenta-1,3-diene-1-thio-
lato-N’, N3,S]bismuth(lll) nitrate (5)
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In the bismuth complexes of group E each time two thiosemicarbazone or dithiocarbazonic
acid methylester derivatives are coordinated to the bismuth(Ill) central atom as bidentate li-
gands via the N(3) atom and the S atom of the thiolate group. There is no coordinative bond
between the sulfur atom in the thiophene ring or the oxygen atom in the furan ring and the
bismuth central atom. The 1H NMR spectra of the bismuth complexes from group E show one
doublet for the ring protons H-7 and H-9 and a doublet of doublets for the proton H-8 in the
range between 6.5-8.1 ppm. In contrast to the free ligands, the shift of the signals is negligi-
ble. Molar conductivities AM, measured in DMF, lie in the range of 47.6-60.6 [Scm2mol1] and
prove that this complex behaves as a 1:1 electrolyte.
28
Compound 9 is assigned to complex type E, its structure is given in Figure 2. Here, two mole-
cules of 1 k, deprotonated in positions N(4) and N(6), are coordinated to the bismuth(Ill) cen-
tral atom as bidentate ligands. The complex bonds are formed by the sulfur atoms of the
thiolate groups S(3) and S(4) and by the nitrogen atoms N(4) and N(6). With the exception of
the hexamethyleneimino ring, the whole ligand lies within a single plane. The structure of the
complex can best be described as a distorted trigonal antiprism, while the central atom is five-
coordinated. The two triangular faces are formed by the atoms S(4), N(6), O(1 1) and S(3),
N(4) and the lone pair of the central atom. The two chelate rings are almost perpendicular to
each other. The Bi(1)-O(11) distance of 289 pm is considered to be an intermolecular interac-
tion, as mentioned before in compound 5. The methanol molecules required for crystal forma-
tion can be found in the gaps of the crystal lattice. In the FD mass spectrum, a peak is
obtained at m/z 769 for the fragment [(Lig)2Bi+]. This is determined by deducting the
mass for the methanol molecule and a nitrate ion from the molar peak.
Figure 2. SCHAKAL plot of Bis[ -azepanyl-4-(2-thienyl)-2,3-diazapenta- 1,3-diene- -thio-
lato-N3,S]bismuth(lll) nitrate (9)
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The complexes of group F are dimeric bismuth(Ill) complexes. The two bismuth central atoms
are bridged via two chlorine atoms. The tridentate chelate ligands are perpendicular to the
Bi2CI2-plane and can have a parallel or antiparallel arrangement. The proton of the N(2)-H
group shows a singlet 1H NMR signal, which can be observed in the range between 9.5 and
1.5 ppm in the case of the free ligands, it disappears completely in the case of the bismuth
complexes of groups D and F. In the 1H NMR spectra, most of the bismuth(Ill) complexes of
group F show a second, weak signal for the protons H-IO and H-13 and in some cases also
for the protons H-9 and H-14. This additional signal is caused by the different possibilities in
which the tridentate ligand can bind to the bismuth atom, as shown in Scheme 2.
Complex 15 is an example of a dimeric bismuth(Ill) complex of group F. Its structure, as
shown in Figure 3, can be described as two six-coordinated bismuth atoms, which are bound
together via two bridging chlorine atoms.
3
c12
Cll
C14
C10 C3(3
N4
CI2a Nla
N3 Cla
N2
C1 N3a
CI2
C6 iC3 C103
C14
CS )C4
Figure 3.
r’ll C13,=
C12
ORTEP plot of the dimeric unit of Di-p-chlorobis[1-azepanyl-4-12-pyridyl)-2,3-
diazapenta- 1,3-diene- -thiolato-N’, N3,S-chloro]dibismuth(lll) (1 5)
The two bismuth atoms Bi(1) and Bi(la) and the two bridging chlorine atoms (31(2) and Cl(2a)
form the Bi2CI plane. The non-bridging chlorine atoms C1(1), Cl(la) almost lie in the Bi2CI2
plane. The greater bond length Bi(1)-CI(2) of 279.1 pm in comparison to 258.5 pm in the case
of Bi(1)-CI(1) is an indication of the bridging function of the C1(2) atom. The Bi(1)-Cl(2a) dis-
tance was determined as 316.2 pm. This is a relatively great bond length for a Bi-CI bond but
can be considered as a covalent bond.
1 The two tridentate ligand molecules coordinate via
the same atoms as shown in complex 5. In addition, they form two parallel planes, which are
perpendicular to the Bi2CI plane. With regard to the center of the Bi(1 )-Bi(2) axis they are cen-
tral point symmetrical, i.e. one pyridine ring lies above and the other beneath the BiCI2 plane.
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The FD mass spectrum shows a typical isotope distribution for three chlorine atoms at m/z
1073, 1075, 1077, 1079, which corresponds to the fragment [(Lig)2Bi2CI3 /], i.e. a chlorine
atom was split off. The molar conductivity AM of 15, measured in DMF, is 8.6 [Scm2moll].
All bismuth complexes of group F show molar co.nductivities in the range between 7.5-9.6
[Scm2mol1] and are therefore assigned to the neutral complexes.
8
It was not possible to obtain chloro-bridged dimeric bismuth(Ill) complexes from the ligands 1
b and 1 c, which are not alkylated at the N(12) atom. These two complexes are assigned to
group G, where three chlorine atoms and a bidentate ligand are coordinated to the bismuth(Ill)
central atom. The bidentate ligand is bound to the central atom through the N(3) atom and the
sulfur atom of the thioketo group. It can be seen from the H NMR spectra that the N(2)-H
group has the deprotonated form. For the N(2)-H proton, singulets are observed at 11.78 ppm
(19) and at 11.35 ppm (20). If the 13C NMR spectrum of 1 b is compared with the lzC NMR
spectra of the bismuth complexes 1 and 19, synthesized with these ligands, it can be demon-
strated that the ligand is bound to the bismuth(Ill) central atom in different ways. While the
carbon signals in complex 19 show only a minor shift against the free ligand, they show
markedly changed chemical shifts in complex 1. The complex bond to the N(3) atom, which is
formed during the complexation of 1 b to the bismuth(Ill) cation, effects a polarisation of the
C=N azomethine bond. Due to the reduced electron density, the C(4) signal is shifted by 5
ppm to the lower field. The shift into the high field of the C(1) signal is caused by the keto-
enol tautomerism at the C(1) atom. The signals of the ring carbon atoms show a marked ten-
dency towards the lower field. Yet our attempts to resolve the molecular structure of this
group of bismuth complexes by crystal structure analyses have been unsuccessful.
On analysis of the reaction product of ligand 1 k and bismuth(Ill) chloride, we were surprised
to obtain a complex of a fifth group H, the structure of which differs from the other four
groups in several ways.
The structure of 18 is completely different from the structures of the bismuth(Ill) complexes
discussed so far. The bismuth central atom is coordinated with two ligands of 1 k, which are
bound in different ways. One of the two ligand molecules is deprotonated. This ligand is
bound to the central atom via the sulfur atom S(3) of the thiolate group and the N(5) atom.
The thiophene ring is cis-configurated with regard to the N(5)=C(15) bond, with the result
that an interaction of S(4) with Bi(1) is not possible. The second molecule of 1 k is not depro-
tonated. This ligand is bound to the bismuth(Ill) cation merely via the sulfur atom S(1) of the
thioketo group. The value for the distance between Bi(1) and S(1) of 299.2 pm corresponds
to an intermolecular interaction and not to a covalent bond. The best description of the coor-
dination sphere of the bismuth atom is that of a distorted square bipyramidal polyhedron. The
square face is formed by the atoms S(3), N(5), C1(1), the lone pair and the bismuth atom
within. The axial positions are occupied by the atoms S(1) and C1(2). The bond angle between
S(1), Bi(1) and C1(2) differs by about eight degrees from the value determined for a regular
square bipyramidal polyhedron of 180 degrees. In the H NMR spectrum, a singulet can be
observed at 9.42 ppm, which is caused by the proton of the N(2)-H group of the protonated
ligand. For the protons of the pyridine rings and the H-5 protons, three different signals are
mostly found. The different signals can be produced by the possible Z,E isomerism within the
protonated ligand on the one hand and by the difference in the binding of the ligands to the
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bismuth central atom on the other. The FD mass spectrum shows two signals at m/z 804,
806 with the typical isotope distribution for one chlorine atom. This fragment, [(Lig)2BiCI /], is
obtained when deducting the mass of one HCI (X 36) from the molar mass. A further sig-
nal at m/z 769 is assigned to the fragment [(HMTH)2Bi/]. The molar conductivity of 3.0
[ScmZmol1] in DMF shows that complex 18 is a neutral complex.
8
CIO
Figure 4. SCHAKAL plot of [1-azepanyl-4-(2-thienyl)-2,3-diazapenta-1,3-diene-1-thiola-
to-N3, S]-[ -azepanyl-4-(2-thienyl)-2,3-diazapent-3-ene- -thiolketo-S]dichloro-
bismuth(Ill) (18)
There seems to be a relationship between the molecular structure of bismuth(Ill) compounds,
their solubility and their biological activity against H. pylori bacteria. In our in vitro experi-
ments, the dimeric bichlorobridged complexes are less soluble and less active than the mono-
meric species, obtained by reaction of bismuth(Ill) nitrate and the same thiosemicarbazone
that was used to synthesize the dimeric compound. It would be interesting if these tendencies
could be observed in studies at gastrointestinal pH values. Therefore further experiments con-
cerning the stability of the new compounds at 37 C and pH (stomach, mucosa) or pH 10
(intestine) must be carried out.
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